NOTA Laboratories Completes Venture Capital Funding Round Led By Pegasus Tech Ventures
Summary
ANN ARBOR, Mich., Sept. 15, 2022 /PRNewswire/ -- NOTA Laboratories, a development stage company focused on proprietary nitric oxide (NO) delivery systems to treat a wide variety of serious respiratory and inflammatory illnesses, has just completed its second round of financing led by Pegasus Tech Ventures, a global venture capital firm based in Silicon Valley. LANOR is also small, lightweight and can be battery operated, making it ideal for both emergency and in-home use.Nitric oxides biological importance was only discovered in the 1980s and has since garnered a tremendous amount of attention from biomedical researchers with over 20,000 publications and 400 ongoing clinical trials using NO for a range of applications. NOTAs systems can be used to augment the bodys NO production for potentially life-saving applications like persistent pulmonary hypertension of the newborn (PPHN), reducing systemic inflammation response syndrome (SIRS) during and after cardiopulmonary bypass (CPB) surgery, for use in treating respiratory infections and their associated inflammatory response, and for chronic obstructive pulmonary disease (COPD).Malcolm Kahn, NOTAs CEO said, "We are pleased about our expanding relationship with Pegasus and the synergies their investor partners bring to the table." Bill Reichert, Partner at Pegasus Tech Ventures, noted, "We are delighted with the progress that the NOTA team has made toward a commercial product, and we are very excited about the potential to deliver NO in a broad range of disease indications using a safer, more cost-effective medical device. "NOTAs other proprietary NO delivery technologies, which are single-use infection fighting disposables, including a sinus spray, a sachet that can be placed into a face mask and two catheter products, have been spun out into a separately run startup called NOxygen Therapeutics.Pegasus Tech Ventures is a global venture capital firm based in Silicon Valley with $2 Billion in assets under management.